5[6]Gralla R, Harper P, Johnson S, et al. Vinorelbine (Navel bine) in the treatment of non-small cell lung cancer: studies with single-agent therapy and in combination with cisplatin[J]. Ann Oncol, 1999,10 (Suppl 5): S41-S45.
6[8]HohnekerJA. A summary of Vinorelbine (Navelbine) safety data from north American clinical trials[J]. Semin Oncology, 1994, 21(5 Suppl 10):42.
7Vallejo C,Romero A,Perez J,et al.Ifosfamide and vinorelbineas flint-line chemotherapy for advanced nonsmall cell lung carcinoma[J].Am J Clin Oncol,1996,19(6):584.
8Le Chevalier T,Briagand D,Sofia J C,et al.Long term analysis of survival in the European randomized trial comparing vinorelbine/cisplatin to vindesine/cisplatin and vinorelbine alone in advanced non-small cell lung cancer[J].Oncologist,2001,6(Suppl) 1:8-11.
9Li YF,Zhang R.Reversed-phase high-performance liquid chromatography method for the simultaneous quantitation of the lactone and carboxylate forms of the novel natural product anticancer agent 10-hydroxycamptothecin in biological fluids an d tissues[J].J Chromatogr B Biomed Appl,1996,686(2):257-265.
10Greewald RB,Choe YH,Wu D.Selective phenolic acylation of 10-hydroxycamptothecin using poly (ethylene Oycol) carboxylic acid[J].Bioorg Med Chem Lett,2003,13(3):577-580.
